Progressive pulmonary hypertension post atrial septal defect device closure-early symptomatic improvement may not predict outcome

Heart Lung and Circulation

Volumn 19, Issue 12, 2010, Pages 713-716

  O'Donnell, C ^a   Ruygrok, P N ^b   Whyte, K ^b   Wilson, N J ^a  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Atrial septal defect; Congenital heart disease; Interventional cardiology; Pulmonary arterial hypertension

Indexed keywords

BOSENTAN; NIFEDIPINE; SILDENAFIL; VASODILATOR AGENT; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BYPASS SURGERY; CHILD; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART FAILURE; HEART SURGERY; HEMODYNAMICS; HUMAN; HYPOTENSION; HYPOXIA; LEIOMYOSARCOMA; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; SEPTAL OCCLUDER DEVICE; TREATMENT OUTCOME;

EID: 78149465755     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2010.08.010     Document Type: Article

References (16)

1. Veldtman G.R., Razack V., Siu S., El Hajj H., Walker F., Webb G.D., Benson L.N., McLaughlin P.R. Right ventricular form and function after percutaneous atrial septal defect device closure. J Am Coll Cardiol 2001, 37:2108-2113.
2. Webb G., Gatzoulis M.A. Atrial septal defects in the adult: recent progress and overview. Circulation 2006, 114:1645-1653.
3. Steele P.M., Fuster V., Cohen M., Ritter D.G., McGoon D.C. Isolated atrial septal defect with pulmonary vascular obstructive disease-long-term follow-up and prediction of outcome after surgical correction. Circulation 1987, 76:1037-1042.
4. Kimball K.G., McIlroy M.B. Pulmonary hypertension in patients with congenital heart disease. Pre- and postoperative hemodynamics, pulmonary function, and criteria for surgical closure of defects. Am J Med 1966, 41:883-897.
5. Kirklin J.W., Barratt-Boyes B.G. Atrial septal defect and partial anomalous pulmonary venous connection. Cardiac surgery 1993, 634. Churchill Livingstone Inc., New York. 2nd ed. J.W. Kirklin, B.G. Barratt-Boyes (Eds.).
6. Sharp A., Malik I. Secundum atrial septal defects: time to close them all?. Heart 2008, 94:1120-1122.
7. Althoff T.F., Knebel F., Panda A., McArdle J., Gliech V., Franke I., Witt C., Baumann G., Borges A.C. Long-term follow-up of a fenestrated Amplatzer atrial septal occluder in pulmonary arterial hypertension. Chest 2008, 133:283-285.
8. Elshershari H., Cao Q.L., Hijazi Z.M. Transcatheter device closure of atrial septal defects in patients older than 60 years of age: immediate and follow-up results. J Invasive Cardiol 2008, 20:173-176.
9. Frost A.E., Quinones M.A., Zoghbi W.A., Noon G.P. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant 2005, 24:501-503.
10. Hoetzenecker K., Ankersmit H.J., Bonderman D., Hoetzenecker W., Seitelberger R., Klepetko W., Lang I.M. Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: a case report. J Thorac Cardiovasc Surg 2009, 137:760-761.
11. Majunke N., Bialkowski J., Wilson N., Szkutnik M., Kusa J., Baranowski A., Heinisch C., Ostermayer S., Wunderlich N., Sievert H. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol 2009, 103:550-554.
12. Balint O.H., Samman A., Haberer K., Tobe L., McLaughlin P., Siu S.C., Horlick E., Granton J., Silversides C.K. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart 2008, 94:1189-1193.
13. Schwerzmann M., Zafar M., McLaughlin P.R., Chamberlain D.W., Webb G., Granton J. Atrial septal defect closure in a patient with "irreversible" pulmonary hypertensive arteriopathy. Int J Cardiol 2006, 110:104-107.
14. Wilson N.J., Smith J., Prommete B., O'Donnell C., Gentles T.L., Ruygrok P.N. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias. Heart Lung Circ 2008, 17:318-324.
15. de Lezo J.S., Medina A., Romero M., Pan M., Segura J., Caballero E., Pavlovic D., Ortega J.R., Franco M., Delgado A., Ojeda S., Mesa D., Lafuente M. Effectiveness of percutaneous device occlusion for atrial septal defect in adult patients with pulmonary hypertension. Am Heart J 2002, 144:877-880.
16. Yong G., Khairy P., De Guise P., Dore A., Marcotte F., Mercier L., Noble S., Ibrahim R. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects. A longitudinal study. Circ Cardiovasc Intervent 2009, 2:455-462.